의료 분야 증강현실(AR) 및 가상현실(VR) 시장 규모, 점유율, 동향 분석 보고서 : 구성 요소별, 기술별, 지역별 및 부문별 전망(2026-2033년)

The global augmented reality and virtual reality in healthcare market size was valued at USD 4.6 billion in 2025 and is projected to grow from USD 5.4 billion in 2026 to USD 19.0 billion in 2033, at a CAGR of 19.6% from 2026 to 2033. The North America dominated the market, accounting for a revenue share of 40.0% in 2025. Technological advancements and digitalization in healthcare, favorable government initiatives, rising healthcare expenditure, growing use of surgical procedures, and medical training are among the fundamental factors anticipated to drive the growth and adoption of augmented reality (AR) and virtual reality (VR) technologies in the healthcare industry.

Augmented Reality (AR) and Virtual Reality (VR) are pivotal innovations in immersive technology. AR enhances our perception of the real world by integrating digital information, such as sounds, images, or text, into our view of our surroundings. This capability facilitates interactive experiences and allows for the visualization of complex concepts in a tangible context. On the other hand, VR provides immersive experiences, transporting users into simulated environments. This allows for interaction in a digital space that offers an experience distinct from the real world. These technologies are essential in advancing user engagement and understanding across various sectors.

In the field of medical education, virtual reality is revolutionizing training by providing immersive, interactive experiences that enhance knowledge retention and create risk-free environments. For instance, in June 2026, Elsevier launched Shadow Health Lab with Virtual Reality, an immersive clinical simulation platform. This platform is designed to support nursing education through virtual patient encounters and evidence-based training scenarios. It enables students to practice clinical decision-making and patient-interaction skills in a realistic virtual environment, allowing healthcare learners to gain practical experience without risking actual patients. This development highlights the growing adoption of VR-based medical education solutions to improve clinical preparedness, knowledge retention, and the efficiency of workforce training.

AR is significantly transforming medical education by allowing students to explore anatomical structures and disease pathologies through an interactive, 3D format. For instance, in March 2024, Siemens Healthineers launched its Cinematic Reality application for Apple Vision Pro. This application enables surgeons, medical students, and patients to interact with immersive, three-dimensional holographic representations of human anatomy generated from medical imaging data. Users can visualize and manipulate realistic anatomical renderings, enhancing applications in medical education, patient communication, and surgical planning. This development underscores the growing adoption of augmented reality and spatial computing technologies in healthcare education by enabling interactive visualization of complex anatomical structures and improving clinical learning experiences.

Augmented Reality And Virtual Reality in the Healthcare Market Report Segmentation

This report forecasts revenue growth and provides analysis at the global, regional, and country levels of the latest trends in each sub-segment from 2021 to 2033. For this report, Grand View Research has segmented the global augmented reality and virtual reality in healthcare market report based on component, technology, and region:

• Component Outlook (Revenue, USD Billion, 2021 - 2033)

Hardware

Software

Services

• Technology Outlook (Revenue, USD Billion, 2021 - 2033)

Augmented Reality

• Surgical Application
• Rehabilitation
• Training & Continuing Medical Education

Virtual Reality

• Simulation
• Diagnostics
• Virtual Reality Exposure Therapy (VRET)
• Rehabilitation
• Pain Distraction
• Regional Outlook (Revenue, USD Billion, 2021 - 2033)

North America

• U.S.
• Canada
• Mexico

Europe

• UK
• Germany
• France
• Italy
• Spain
• Sweden
• Denmark
• Norway

Asia Pacific

• Japan
• China
• India
• Australia
• South Korea
• Thailand

Latin America

• Brazil
• Argentina

Middle East & Africa

• Saudi Arabia
• South Africa
• UAE
• Kuwait

Table of Contents

Chapter 1. Research Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Component
  • 1.1.2. Technology Type
  • 1.1.3. Regional scope
  • 1.1.4. Estimates and forecast timeline.
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database.
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
  • 1.6.2. Approach 1: Commodity flow approach
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Component outlook
  • 2.2.2. Technology Type outlook
  • 2.2.3. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Augmented Reality And Virtual Reality In Healthcare Market Variables, Trends & Scope

• 3.1. Market Dynamics
  • 3.1.1. Market Driver Analysis
    • 3.1.1.1. Increasing Adoption of Immersive Technologies in Medical Training and Education
    • 3.1.1.2. Rising Demand for Minimally Invasive and Image-Guided Surgical Procedures
    • 3.1.1.3. Growing Utilization of VR in Rehabilitation, Pain Management, and Mental Health Therapies
  • 3.1.2. Market Restraint Analysis
    • 3.1.2.1. High Implementation Costs and Limited Reimbursement Frameworks
    • 3.1.2.2. Technical Integration Challenges and Data Privacy Concerns
  • 3.1.3. Market Challenges Analysis
  • 3.1.4. Market Opportunities Analysis
• 3.2. Augmented Reality And Virtual Reality In Healthcare Market Analysis Tools
  • 3.2.1. Industry Analysis - Porter's
    • 3.2.1.1. Supplier power
    • 3.2.1.2. Buyer power
    • 3.2.1.3. Substitution threat
    • 3.2.1.4. Threat of new entrant
    • 3.2.1.5. Competitive rivalry
  • 3.2.2. PESTEL Analysis
    • 3.2.2.1. Political landscape
    • 3.2.2.2. Economic landscape
    • 3.2.2.3. Social landscape
    • 3.2.2.4. Technological landscape
    • 3.2.2.5. Environmental landscape
    • 3.2.2.6. Legal landscape
• 3.3. Emerging Technology
• 3.4. Case Studies & Insights
• 3.5. Use Cases

Chapter 4. Augmented Reality And Virtual Reality In Healthcare Market: Component Estimates & Trend Analysis

• 4.1. Component Segment Dashboard
• 4.2. Component Market Share Movement Analysis, 2025 & 2033
• 4.3. Market Size & Forecasts and Trend Analysis, by Component, 2021 to 2033 (USD Million)
• 4.4. Hardware
  • 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Software
  • 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Service
  • 4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Augmented Reality And Virtual Reality In Healthcare Market: Technology Type Estimates & Trend Analysis

• 5.1. Technology Model Segment Dashboard
• 5.2. Technology Model Market Share Movement Analysis, 2025 & 2033
• 5.3. Market Size & Forecasts and Trend Analysis, by Technology Model, 2021 to 2033 (USD Million)
• 5.4. Augmented reality
  • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4.2. Surgical Applications
    • 5.4.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4.3. Rehabilitation
    • 5.4.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4.4. Training and Continuing Medical Education
    • 5.4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Virtual reality
  • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5.2. Simulation
    • 5.5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5.3. Diagnostics
    • 5.5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5.4. Virtual Reality Exposure Therapy (VRET)
    • 5.5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5.5. Rehabilitation
    • 5.5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5.6. Pain Distraction
    • 5.5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Augmented Reality And Virtual Reality In Healthcare Market: Regional Estimates & Trend Analysis, By Component and Technology Type

• 6.1. Regional Market Dashboard
• 6.2. Regional Market Share Analysis, 2025 & 2033
• 6.3. North America
  • 6.3.1. U.S.
    • 6.3.1.1. Key country dynamics
    • 6.3.1.2. Regulatory framework
    • 6.3.1.3. Competitive scenario
    • 6.3.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.3.2. Canada
    • 6.3.2.1. Key country dynamics
    • 6.3.2.2. Regulatory framework
    • 6.3.2.3. Competitive scenario
    • 6.3.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.3.3. Mexico
    • 6.3.3.1. Key country dynamics
    • 6.3.3.2. Regulatory framework
    • 6.3.3.3. Competitive scenario
    • 6.3.3.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
• 6.4. Europe
  • 6.4.1. UK
    • 6.4.1.1. Key country dynamics
    • 6.4.1.2. Regulatory framework
    • 6.4.1.3. Competitive scenario
    • 6.4.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.4.2. Germany
    • 6.4.2.1. Key country dynamics
    • 6.4.2.2. Regulatory framework
    • 6.4.2.3. Competitive scenario
    • 6.4.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.4.3. France
    • 6.4.3.1. Key country dynamics
    • 6.4.3.2. Regulatory framework
    • 6.4.3.3. Competitive scenario
    • 6.4.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.4.4. Italy
    • 6.4.4.1. Key country dynamics
    • 6.4.4.2. Regulatory framework
    • 6.4.4.3. Competitive scenario
    • 6.4.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.4.5. Spain
    • 6.4.5.1. Key country dynamics
    • 6.4.5.2. Regulatory framework
    • 6.4.5.3. Competitive scenario
    • 6.4.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.4.6. Norway
    • 6.4.6.1. Key country dynamics
    • 6.4.6.2. Regulatory framework
    • 6.4.6.3. Competitive scenario
    • 6.4.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.4.7. Sweden
    • 6.4.7.1. Key country dynamics
    • 6.4.7.2. Regulatory framework
    • 6.4.7.3. Competitive scenario
    • 6.4.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.4.8. Denmark
    • 6.4.8.1. Key country dynamics
    • 6.4.8.2. Regulatory framework
    • 6.4.8.3. Competitive scenario
    • 6.4.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
• 6.5. Asia Pacific
  • 6.5.1. Japan
    • 6.5.1.1. Key country dynamics
    • 6.5.1.2. Regulatory framework
    • 6.5.1.3. Competitive scenario
    • 6.5.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5.2. China
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Regulatory framework
    • 6.5.2.3. Competitive scenario
    • 6.5.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5.3. India
    • 6.5.3.1. Key country dynamics
    • 6.5.3.2. Regulatory framework
    • 6.5.3.3. Competitive scenario
    • 6.5.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5.4. Australia
    • 6.5.4.1. Key country dynamics
    • 6.5.4.2. Regulatory framework
    • 6.5.4.3. Competitive scenario
    • 6.5.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5.5. South Korea
    • 6.5.5.1. Key country dynamics
    • 6.5.5.2. Regulatory framework
    • 6.5.5.3. Competitive scenario
    • 6.5.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5.6. Thailand
    • 6.5.6.1. Key country dynamics
    • 6.5.6.2. Regulatory framework
    • 6.5.6.3. Competitive scenario
    • 6.5.6.4. Singapore market estimates and forecasts 2021 to 2033 (USD Million)
• 6.6. Latin America
  • 6.6.1. Brazil
    • 6.6.1.1. Key country dynamics
    • 6.6.1.2. Regulatory framework
    • 6.6.1.3. Competitive scenario
    • 6.6.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6.2. Argentina
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Regulatory framework
    • 6.6.2.3. Competitive scenario
    • 6.6.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
• 6.7. MEA
  • 6.7.1. South Africa
    • 6.7.1.1. Key country dynamics
    • 6.7.1.2. Regulatory framework
    • 6.7.1.3. Competitive scenario
    • 6.7.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7.2. Saudi Arabia
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Regulatory framework
    • 6.7.2.3. Competitive scenario
    • 6.7.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7.3. UAE
    • 6.7.3.1. Key country dynamics
    • 6.7.3.2. Regulatory framework
    • 6.7.3.3. Competitive scenario
    • 6.7.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7.4. Kuwait
    • 6.7.4.1. Key country dynamics
    • 6.7.4.2. Regulatory framework
    • 6.7.4.3. Competitive scenario
    • 6.7.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
• 7.3. Key company market share/position analysis, 2025
• 7.4. Company Profiles
  • 7.4.1. Microsoft
    • 7.4.1.1. Company overview
    • 7.4.1.2. Financial performance
    • 7.4.1.3. Product benchmarking
    • 7.4.1.4. Strategic initiatives
  • 7.4.2. Medtronic
    • 7.4.2.1. Company overview
    • 7.4.2.2. Financial performance
    • 7.4.2.3. Product benchmarking
    • 7.4.2.4. Strategic initiatives
  • 7.4.3. Siemens Healthineers
    • 7.4.3.1. Company overview
    • 7.4.3.2. Financial performance
    • 7.4.3.3. Product benchmarking
    • 7.4.3.4. Strategic initiatives
  • 7.4.4. GE HealthCare
    • 7.4.4.1. Company overview
    • 7.4.4.2. Financial performance
    • 7.4.4.3. Product benchmarking
    • 7.4.4.4. Strategic initiatives
  • 7.4.5. Philips
    • 7.4.5.1. Company overview
    • 7.4.5.2. Financial performance
    • 7.4.5.3. Product benchmarking
    • 7.4.5.4. Strategic initiatives
  • 7.4.6. Surgical Theater
    • 7.4.6.1. Company overview
    • 7.4.6.2. Financial performance
    • 7.4.6.3. Product benchmarking
    • 7.4.6.4. Strategic initiatives
  • 7.4.7. Osso VR
    • 7.4.7.1. Company overview
    • 7.4.7.2. Financial performance
    • 7.4.7.3. Product benchmarking
    • 7.4.7.4. Strategic initiatives
  • 7.4.8. CAE Healthcare
    • 7.4.8.1. Company overview
    • 7.4.8.2. Financial performance
    • 7.4.8.3. Product benchmarking
    • 7.4.8.4. Strategic initiatives
  • 7.4.9. XRHealth
    • 7.4.9.1. Company overview
    • 7.4.9.2. Financial performance
    • 7.4.9.3. Product benchmarking
    • 7.4.9.4. Strategic initiatives
  • 7.4.10. MindMotion
    • 7.4.10.1. Company overview
    • 7.4.10.2. Financial performance
    • 7.4.10.3. Product benchmarking
    • 7.4.10.4. Strategic initiatives
  • 7.4.11. VirtaMed
    • 7.4.11.1. Company overview
    • 7.4.11.2. Financial performance
    • 7.4.11.3. Product benchmarking
    • 7.4.11.4. Strategic initiatives
  • 7.4.12. FundamentalVR (FundamentalXR)
    • 7.4.12.1. Company overview
    • 7.4.12.2. Financial performance
    • 7.4.12.3. Product benchmarking
    • 7.4.12.4. Strategic initiatives